Related Experiment Video
Updated: Jul 14, 2026

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction
Published on: January 29, 2019
Radiolabeled divalent peptidomimetic vitronectin receptor antagonists as potential tumor radiotherapeutic and imaging
Thomas D Harris1, Edward Cheesman, Anthony R Harris
1Discovery Research, Bristol-Myers Squibb Medical Imaging, North, Billerica, Massachusetts 01862, USA. tdharris911@comcast.net
Abstract:
The integrin receptor alphavbeta3 is overexpressed on the endothelial cells of growing tumors and on some tumor cells themselves. A radiolabeled alphavbeta3 antagonists belonging to the quinolin-4-one class of peptidomimetics (TA138) was previously shown to exhibit high affinity for integrin alphavbeta3 and high selectivity versus other integrin receptors. 111In-TA138 exhibited high tumor uptake in the c-neu Oncomouse mammary adenocarcinoma model and produced excellent scintigraphic images. This study describes the synthesis of eight divalent versions of TA138 and their evaluation as potential tumor radiotherapeutic agents. The two main variables in this study were the length of the spacer bridging the biotargeting moieties and the total negative charge of the molecules imparted by the cysteic acid pharmacokinetic modifiers. Receptor affinity was evaluated in a panel of integrin receptor affinity assays, and biodistribution studies using the 111In-labeled derivatives were carried out in the c-neu Oncomouse model. All divalent agents maintained the high receptor affinity and selectivity of TA138, and six of the eight 111In derivatives exhibited blood clearance that was faster than 111In-TA138 at 24 h postinjection (PI). All divalent agents exhibited tumor uptake and retention at 24 h PI that was higher than 111In-TA138. Tumor/organ ratios were improved for most of the divalent agents at 24 h PI in critical nontarget organs marrow, kidney, and liver, with the agents having intermediate-length spacers (29-43 A) showing the largest improvement. As an example, 111In-15 showed tumor uptake of 14.3% ID/g at 24 h PI and tumor/organ ratios as follows: marrow, 3.24; kidney, 7.29; liver, 8.51. A comparison of therapeutic indices for 90Y-TA138 and 177Lu-15 indicate an improved therapeutic index for the divalent agent. The implications for radiotherapeutic applications and the mechanism of this multivalent effect are discussed.
Insights
New divalent integrin alphavbeta3 antagonists show enhanced tumor uptake and retention compared to the original TA138. These radiolabeled agents offer improved tumor targeting and therapeutic potential for cancer treatment.
Area of Science:
- Biomedical Imaging
- Radiopharmaceutical Chemistry
- Oncology
Background:
- Integrin alphavbeta3 is a key target in cancer, overexpressed on tumor vasculature and cells.
- TA138, a radiolabeled alphavbeta3 antagonist, shows high affinity and selectivity, with good tumor uptake in preclinical models.
Purpose of the Study:
- To synthesize and evaluate novel divalent versions of TA138 as potential tumor radiotherapeutic agents.
- To investigate the impact of spacer length and molecular charge on the efficacy of these new agents.
Main Methods:
- Synthesis of eight divalent TA138 analogs with varying spacer lengths and charges.
- Evaluation of receptor affinity using integrin receptor binding assays.
- Biodistribution studies of 111In-labeled derivatives in the c-neu Oncomouse model.
Main Results:
- All divalent agents retained high affinity and selectivity for integrin alphavbeta3.
- Six of eight agents showed faster blood clearance than 111In-TA138 at 24 hours postinjection.
- Divalent agents exhibited higher tumor uptake and retention, with improved tumor-to-organ ratios, especially those with intermediate spacers.
Conclusions:
- Divalent TA138 analogs demonstrate enhanced tumor targeting and retention compared to the parent compound.
- These agents hold promise for improved radiotherapeutic applications in cancer treatment.
- The multivalent effect contributes to improved therapeutic indices, suggesting potential for enhanced efficacy.
Related Concept Videos
Imaging Studies II: Positron Emission Tomography and Scintigraphy
Fundamental Principles of PET
Positron Emission Tomography
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body being...

